Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Certara, a leader in biosimulation, announced that its CEO, William F. Feehery, and CFO, Andrew Schemick, will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference. The event is scheduled for November 22, 2021, at 10:00 am ET. Interested parties can access the webcast through Certara's investor relations website. Certara is known for its proprietary biosimulation software, serving over 1,650 global biopharmaceutical firms, academic institutions, and regulatory agencies across 61 countries.

News Market Reaction 1 Alert

+0.23% News Effect

On the day this news was published, CERT gained 0.23%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

11/03/2021 - 08:00 AM

PRINCETON, N.J., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William F. Feehery, Chief Executive Officer, and Andrew Schemick, Chief Financial Officer will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference.

A webcast of the fireside chat will be available beginning Monday, November 22, 2021, at 10:00 am ET on Certara’s investor relations website at https://ir.certara.com.

About Certara
Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Ariane Lovell
Finn Partners
ariane.lovell@finnpartners.com